Phone:  (310) 825-8816
Fax:  (310) 206-9111
chf@mednet.ucla.edu

  

Publications


HEART FAILURE AND HEART TRANSPLANT PUBLICATIONS BY AHMANSON-UCLA CARDIOMYOPATHY CENTER STAFF AND THEIR COLLABORATORS
Assessment of
Heart Failure		 Hemodynamics and
Heart Failure		 Tailored Therapy
for Heart Failure		 Sudden Death/
Mortality		 Autonomic
Nervous System		 Heart
Transplant		 Quality
of Life

Therapy for Heart Failure

  1. Dracup K, Baker DW, Dunbar SB, Dacey RA, Brooks NH, Johnson JC, Oken C, Massie BM. Management of heart failure. II. Counseling, education, and lifestyle modifications. JAMA 1994;272:14426

  2. Dracup K, Dunbar SB, Baker DW. Rethinking heart failure. Am J Nurs 1995;95:227

  3. Dunbar SB, Dracup K. Agency for health care policy and research: Clinicalpractice guidelines for heart failure. J Cardiovasc Nurs 1996;10:858

  4. Hamilton MA, Stevenson LW, Child JS, Moriguchi JD, Woo MA. Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure. Am J Cardiol 1990;65:1209-1212.

  5. Hamilton MA, Stevenson LW, Child JS, Moriguchi JD, Walden J, Woo MA. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. Am J Cardiol 1991;67:259-263.

  6. Fonarow GC, ChelimskyFallick C, Stevenson LW, Luu M, Hamilton MH, Moriguchi JD, Tillisch JH, Walden JA, Albanese E: Effect of direct vasodilation with hydralazine versus angiotensinconverting enzyme inhibition with captopril on mortality in advanced heart failure: the HyC trial. J Am Coll Cardiol 1992;19:842850

  7. Pfeffer MA, Stevenson LW. Betaadrenergic blockers and survival in heart failure. N Engl J Med 1996;334:13967

  8. Middlekauff HR, Stevenson WG, Saxon LA, Stevenson LW. Amiodarone and torsades de pointes in patients with advanced heart failure. Am J Cardiol 1995;76:499502

  9. Stevenson LW, Dracup KA, Tillisch JH: Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. Am J Cardiol 1989;63:461464

  10. Stevenson LW Sietsma K, et al. Exercise capacity for survivors of stable heart failure. Circulation 1990;81:78-85

  11. Stevenson LW. Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. J Heart Lung Transplant 1991;10:468-476

  12. Stevenson LW, Brunken RC, et al. Afterload reduction decreases mitral regurgitation during exercise in advanced heart failure. J Am Coll Cardiol 1990;15:174-180

  13. Stevenson LW, Steimle AE, Fonarow G, Kermani M, Kermani D, Hamilton MA, Moriguchi JD, Walden J, Tillisch JH, Drinkwater DC, et al. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol 1995;25:16370

  14. Stevenson LW. Modern management of heart failure. Hosp Pract 1996;31:1036,10910

  15. Stevenson WG, Middlekauff HR: Antiarrhythmic drug response in patients at riskfor sustained ventricular arrhythmias: can we identify successful longterm responders? J Cardiovasc Electrophysiol 1991;2 (suppl):S212S220

  16. Stevenson WG. Mechanisms and management of arrhythmias in heart failure. Curr Opin Cardiol 1995;10:27481

  17. Drazner MH, Hamilton MA, Fonarow G, Creaser J, Flavell C, Stevenson LW.  Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant. 1999;11:1126-32.

  18. Westlake C, Dracup K, Walden JA, Fonarow G.  Sexuality of patients with advanced heart failure and their spouses or partners.  J of Heart Lung Transplant. 1999;11:1133-8.

  19. Negrao CE, Hamilton MA, Fonarow GC, Hage A, Moriguchi JD, Middlekauff HR. Impaired endothelium-mediated vasodilation is not the principal cause of vasoconstriction in heart failure.  Am J of Physiol Heart Circ Physiol, 2000;278:H168-H174.

  20. Middlekauff HR, Nitzsche EU, Hoh CK, Hamilton MA, Fonarow GC, Hage A, Moriguchi JD.  Exaggerated renal vasoconstriction during exercise in heart failure.  Circulation 2000:101;784-789.

  21. Yoon HC, Goldin JG, Greaser LE, Sayre J, Fonarow GC.  Interscan variation in coronary artery calcium quantification in a large asymptomatic patient population. Am J Roentgenol. 2000, 174:803-809.

  22. Fonarow GC, Gawlinksi A.  Rationale and Design of the cardiac hospitalization atherosclerosis management program at the University of California Los Angeles. Am J Cardiol, 2000, 85:10A-17A.

  23.  Fonarow GC, Wiener I, Feliciano Z, Knight L, Woo MA, Moriguchi JD, Boyle N, Laks H Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable defibrillator. Am J Cardiol, 2000, 85:981-85.

  24. Fonarow GC. How old is too old for heart transplantation? Curr Opin Cardiol. 2000;15:97-103.

  25. Sen L, Cui G, Fonarow GC, Laks H.  Differences in mechanisms of SR dysfunction in ischemic vs. idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2000;279:H709-718.

  26. Marelli D, Laks H, Fazio D, Hamilton MA, Fonarow GC, Meehan DA, Moriguchi JD. Mechanical assist strategy using the BVS 5000i for patients with heart failure.  Ann Thorac Surg. 2000;70:59-66.

  27. Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, Creaser JA, Stevenson LW.  Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart Journal; 2000; 140:840-847.

  28. King ML, Dracup KA, Fonarow GC, Woo MA. The hemodynamic effects of isotonic exercise using hand-held weights in patients with heart failure. J Heart Lung Transplant 2000;19:1209-1218.

  29. Middlekauff HR, Nitzche EU, Hoh CK, Hamilton MA, Fonarow GC, Hage A, Moriguchi JD.  Exaggerated muscle mechanoreflex control of the reflex renal vasoconstriction in heart failure.  J of Applied Physiology 2001; 90:1714-1719.

  30. Walden JA, Dracup K, Westlake C, Erickson V, Hamilton MA, Fonarow GC. Educational needs of patients with advanced heart failure and their caregivers.  J Heart Lung Transplant 2001;20:766-769.

  31. Horwich TB, Fonarow GC, Hamilton MA, Maclellan R, Woo MA, Tillisch JI. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001;38:789-95.

  32. Fonarow, GC. Quality indicators for the management of heart failure in vulnerable elders.  Ann Intern Med. 2001;135:694-702.

  33. Westlake C, Dracup K, Creaser J, Livingston N, Heywood JT, Huiskes BL, Fonarow G, Hamilton M. Correlates of health-related quality of life in patients with heart failure.  J Heart Lung Transplant. 2002;31:85-93.

  34. Horwich TB, Fonarow GC. Prevention of heart failure. Curr Cardiol Rep 2002;4:194-9.

  35. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J.  Anemia is associated with worse symptoms, greater impairment in functional capacity, and a significant increase in mortality in patients with advanced heart failure.   J Am Coll Cardiol 2002;39:1780-1786.

  36. Marelli D, Bresson J, Laks H, Kubak B, Fonarow G, Tsai FC, Tran J, Weston SR, Kobashigawa J. Hepatitis C-positive donors in heart transplantation.Am J Transplant. 2002;2:443-7.

  37. Tsai FC, Marelli D, Bresson J, Gjertson D, Kermani R, Patel J, Kobashigawa JA, Laks H, Ardehali A, Brown M, Esmailian F, Fonarow GC, Hage A, Hamilton M, Houston E, Mark M, Moriguchi J, Plunkett M. Use of hearts transplanted from donors with atraumatic intracranial bleeds. J Heart Lung Transplant 2002;21:623-8.

  38. Tsai FC, Marelli D, Bresson J, Gjertson D, Kermani R, Ardehali A, Esmailian F, Hamilton M, Fonarow GC, Moriguchi J, Plunkett M, Hage A, Tran J, Kobashigawa JA, Laks H. Recent trends in early outcome of adult patients after heart transplantation: a single-institution review of 251 transplants using standard donor organs. Am J Transplant 2002;2:539-45.

  39. Pinderski LJ, Fonarow GC, Hamilton MA, Fishbein MC, Marelli D, Moriguchi M, Cohen B, Kobashigawa JA.  Giant cell myocarditis in a young man responsive to lymphocyte cytolytic therapy.  J Heart Lung Transplant 2002;21:818-21.

  40. Horwich TB, Hamilton MA, MacLellan WR, Fonarow GC. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Failure 2002;8:216-224.

  41. Evangelista LS, Dracup K. Doering L, Westalke C, Fonarow GC, Hamilton M.  Emotional well-being of heart failure patients and their caregivers.  J Card Fail 2002;8:300-305.

  42. Middlekauff HR, Hui K, Yu JL, Hamilton MA, Fonarow GC, Moriguchi J, MacLellan WR, Hage A.   Acupuncture inhibits sympathetic activation during mental stress in advanced heart failure patients. J Card Fail 2003;8:399-406.

  43. Laks H, Marelli D, Fonarow GC, Hamilton MA, Ardehali A, Moriguchi JD, Bresson J, Gjertson D,       Kobashigawa JA. Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg 2003;125:49-59.

  44. Horwich TB, Fonarow GC.  Anemia and prognosis in advanced heart failure.  Cardiology Review 2003;20:32-37.

  45. Evangelista LS, Doering L, Dracup K, Westlake C, Hamiton M, Fonarow G.  Compliance behaviors of elderly patients with advanced heart failure.  J Cardiovasc Nurs 2003;18:123-132.

  46. Shekelle PG, Rich MW, Morton SC, Atkinson SW, Tu W, Maglione M, Rhodes S, Barrett M, Fonarow GC, et al.  Efficacy of angiotension-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender and diabetic status.  A meta-analysis of major clinical trials.  J of Am Coll Cardiol 2003;41:1529-1538.

  47. Horwich TB, Patel J, MacLellan RW, Fonarow GC.  Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality in advanced heart failure. Circulation 2003;108:833-838. 

  48. Woo MA, Macey PM, Fonarow GC, Hamilton MA, Harper RM.  Regional brain gray matter loss in heart failure.  J Appl Physiol  2003;95:677-84.

  49. Marelli D, Laks H, Patel B, Kermani R, Marmureanu A, Patel J, Ardehali A, Esmailian F, Fonarow GC, et al.  Heart transplantation in patients with diabetes mellitus in the current era. J Heart Lung Transplant. 2003;22:1091-1097.

  50. Fonarow, GC.  The acute decompensated heart failure national registry (ADHERE):  opportunities to improve care of patients hospitalized with acute decompensated heart failure.   Rev Cardiovasc Med 2003;4:S21-S30.

  51. Fonarow GC, Abraham WT, Gheorghiade M, Cannon CP, Sackner-Bernstein JD, Udelson JE, Konstam MA.  Role of B-Blocker therapy in the postmyocardial infarction patient with and without left ventricular dysfunction consensus guideline.  Critical Pathways in Cardiology 2003;2:239-246.

  52. Horwich TB, MacLellan WR, Fonarow GC.  Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.  J Am Coll Cardiol 2004;43:642-648.

  53. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC.  Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure.  J Am Coll Cardiol 2004;43:1439-44.

  54. Vredevoe DL, Widawski M, Fonarow GC, Hamilton MA, Martínez-Maza O, Gage JR. Interleukin 6 (IL6) Expression and Natural Killer (NK) Cell Dysfunction and Anergy in Heart Failure Patients. .  Am J Cardiol 2004;93:1007-1011.

  55. Gage JR, Fonarow G, Hamilton M, Widawski M, Martínez-Maza O, Vredevoe DL.  Beta blocker and ACE inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure. Neuroimmunomodulation 2004;11:173-180.

  56. Heidenreich PA, Gubens MA, Fonarow GC, Konstam MA, Stevenson LW, Shekelle PG. Cost-effectiveness of screening with B Type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. J Am Coll Cardiol 2004;43:1019-26.

  57. Faxon DP, Schwamm LH, Pasternak RC, Peterson ED, McNeil BJ, Bufalino V, Yancy CW, Brass LM, Baker DW, Bonow RO, Smaha LA, Jones DW, Smith SC Jr, Ellrodt G, Allen J, Schwartz SJ, Fonarow G, Duncan P, Horton K, Smith R, Stranne S, Shine K. Improving Quality of Care Through Disease Management: Principles and Recommendations From the American Heart Association’s Expert Panel on Disease Management. Circulation 2004; 109:2651-2654.

  58. Fonarow GC. Strategies to Improve the Use of Evidence-Based HF Therapies:  Optimize-HF.  Rev Cardiovasc Med 2004;5:S45-54.

  59. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J. Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J. 2004;148:43-51.

  60. Cesario D, Bhargava M, Valderrabano M, Fonarow GC, Wilkoff B, Shivkumar K. Azygos Vein Lead Implantation. J Cardiovasc Electrophysiol. 2004;15:780-783.

  61. Doering LV, Dracup K, Caldwell MA, Moser DK, Erickson VS, Fonarow G, Hamilton M. Is coping style linked to emotional states in heart failure patients?
    J Card Fail. 2004;10:344-9.

  62. Yancy CW, Burnett JC Jr, Fonarow GC, Silver MA. Decompensated heart failure: is there a role for the outpatient use of nesiritide?  Congest Heart Fail. 2004;10:230-6.

  63. Middlekauff HR, Chiu J, Hamilton MA, Fonarow GC, Maclellan WR, Hage A, Moriguchi J, Patel J. Muscle mechanoreceptor sensitivity in heart failure. Am J Physiol Heart Circ Physiol 2004;287:H1937-H1943.

  64. Silver MA, Maisel A, Yancy CW, McCullough PA, Burnett JC Jr, Francis GS, Mehra MR, Peacock WF 4th, Fonarow G, Gibler WB, Morrow DA, Hollander J. BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular Diseases. Congest Heart Fail. 2004 ;10 suppl 3:1-30.

  65. Smooke S, Horwich TB, Fonarow GC.  Insulin Treated Diabetes is Associated with a Marked Increase in Mortality in Patients with Advanced Heart Failure.  Am Heart J 2005;149:168-74.

  66. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-80.

  67. Westlake C, Dracup K, Fonarow G, Hamilton M. Depression in patients with heart failure. J Card Fail. 2005;11:30-5.

back to top

About Us  |  Patient Care  |  Research  |  Faculty & Staff  |  Publications
©2005-2007 AHMANSON-UCLA Cardiomyopathy Center.  Gregg C. Fonarow, MD